Mark Dowar
Impact in
-
- Cancer Genomics and Diagnostics
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in ⓘ
-
- Cancer Genomics and Diagnostics 7
- Oncology 4
- PARP inhibition in cancer therapy 2
- Co-authors
- Trevor J. Pugh (8 shared papers)Tiantian Li (6 shared papers)Amit M. Oza (4 shared papers)Paul G. Walfish (3 shared papers)Jeremy L. Freeman (3 shared papers)S.Y. Cindy Yang (3 shared papers)Steven Orlov (3 shared papers)Jonathan Yip (2 shared papers)
- Journals
- Head & Neck (3 papers)Nature Genetics (1 paper)Journal of Clinical Oncology (1 paper)Nature Communications (1 paper)Blood Advances (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Mark Dowar
12 papers receiving 456 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 146
- Reproductive Medicine 66
- Hematology 81
- Endocrinology, Diabetes and Metabolism 104
- Oncology 144
Countries citing papers authored by Mark Dowar
This map shows the geographic impact of Mark Dowar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dowar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dowar more than expected).
Fields of papers citing papers by Mark Dowar
This network shows the impact of papers produced by Mark Dowar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dowar. The network helps show where Mark Dowar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dowar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 100 | |
| 2 | 2017 | 73 | |
| 3 | 2018 | 66 | |
| 4 | 2010 | 65 | |
| 5 | 2016 | 57 | |
| 6 | 2012 | 45 | |
| 7 | 2009 | 26 | |
| 8 | 2007 | 13 | |
| 9 | 2018 | 10 | |
| 10 | 2015 | 3 | |
| 11 | 2017 | 1 | |
| 12 | 2016 | 1 |
About Mark Dowar
Mark Dowar is a scholar working on Cancer Research, Oncology, Hematology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 12 papers that have together received 460 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Thyroid and Parathyroid Surgery (2 papers), Neuroendocrine Tumor Research Advances (2 papers), BRCA gene mutations in cancer (2 papers), PARP inhibition in cancer therapy (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Cancer Research (146 citations), Reproductive Medicine (66 citations), Hematology (81 citations), Endocrinology, Diabetes and Metabolism (104 citations) and Oncology (144 citations). Mark Dowar has collaborated with scholars based in Canada and United States. Frequent co-authors include Trevor J. Pugh, Tiantian Li, Amit M. Oza, Paul G. Walfish, Jeremy L. Freeman, S.Y. Cindy Yang, Steven Orlov, Jonathan Yip, Arnavaz Danesh and Blaise Clarke. Their work appears in journals such as Head & Neck, Nature Genetics, Journal of Clinical Oncology, Nature Communications and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.